http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IN-2013MU02603-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b4aefa3af638bab136cfd0da8801334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3948eacb02c3de1de64b9c23d33fdcf8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc55df08a01c5d01098c1280dd0c172c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5117d666d4b27f4ddfe6a133998856c6
publicationDate 2015-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IN-2013MU02603-A
abstract The present invention relates process for preparing active substance pellets containing dabigatran of formula (I). The process for preparing dabigatran pellets using extrusion spheronizer technology, which allows the formulation to be manufactured on a large scale. A further aim of the invention is to provide a process which allows the formulation to be manufactured with a reproducible quality.
priorityDate 2013-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216210

Total number of triples: 14.